Inflammasome Therapeutics
About:
Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Website: https://www.inflam.com
Description:
Inflammasome Therapeutics develops therapies for prevalent, degenerative diseases like Alzheimer’s disease and Parkinson's disease.
Total Funding Amount:
$3.8M
Estimated Revenue Range:
$1M to $10M
Headquarters Location:
Newton, Massachusetts, United States
Founded Date:
2019-01-01
Contact Email:
Info(AT)inflam.com
Founders:
Jayakrishna Ambati, Paul Ashton
Number of Employees:
1-10
Last Funding Date:
2023-08-14
IPO Status:
Private
Industries:
© 2025 bioDAO.ai